Ysios’ investment strategy is to invest in biotech companies looking for first round funding through later-stage.We focus on investing in companies developing innovative therapeutics in Europe and the US, with a special interest in Spain.
We aim to balance risk and liquidity against the stage of investment, from seed capital to pre-IPO-investing, with different therapeutic approaches, time-to-market horizons, capital needs and risk-to-return ratios.
Tipically our investments range from €5 million to €20 million, including additional capital for follow-on investments. For investments in Spain, we typically act as the lead investor, structuring the transaction and always syndicating with other venture capital firms. In major financing operations, especially in those circumstances where we can leverage our global network, we invest in international syndicates with other dedicated life sciences and healthcare investors that share our vision and commitment to investing in and supporting companies. We can lead, co-lead or follow on a case by case basis.